AcousticaBio

Ultra-high concentration antibody formulations for subcutaneous delivery

Built from URL

HealthcarePharmaceuticals & MedicineMedical DevicesBiotechDrug Discovery

MassChallengeU.S. 2021 (winners)

AboutBuilt from URL

AcousticaBio develops ultra-high concentration antibody formulations using proprietary acoustophoretic technology to enable subcutaneous injection delivery. The company helps drug developers formulate biologics into small-volume injections that can be administered at home instead of requiring lengthy hospital-based IV infusions.

ProblemBuilt from URL

See something off about this company?